Y Ariyoshi

Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Mitomycin, Vindesine, and Cisplatin in Unresectable Stage III Non–Small-Cell Lung Cancer

Kiyoyuki Furuse, Masahiro Fukuoka, Masaaki Kawahara et al. · Journal of Clinical Oncology · 1999 · 1.5K citations

Medicine, Oncology, Radiation Oncology +12

Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan

Yuichiro Ohe, Yasuo Ohashi, Kaoru Kubota et al. · Annals of Oncology · 2006 · 637 citations

Medicine, Oncology, Pharmacology +17

A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer.

M. Fukuoka, H Niitani, Atsushi Suzuki et al. · Journal of Clinical Oncology · 1992 · 435 citations

Medicine, Oncology, Pharmacology +16

Predictive Factors for Interstitial Lung Disease, Antitumor Response, and Survival in Non–Small-Cell Lung Cancer Patients Treated With Gefitinib

Masahiko Ando, Isamu Okamoto, Nobuyuki Yamamoto et al. · Journal of Clinical Oncology · 2006 · 361 citations

Medicine, Oncology, Pharmacology +13

p53 Mutations in non-small cell lung cancer in Japan: Association between mutations and smoking

Hideaki Suzuki, Takashi Takahashi, Tetsuo Kuroishi et al. · Lung Cancer · 1992 · 279 citations

Medicine, Genetics, Oncology +12